ABBOTT PARK, Ill. — Abbott and Insulet Corp. announced Wednesday that the companies are partnering to integrate Abbott’s leading glucose sensing technology with Insulet’s next-generation tubeless system, the Omnipod Horizon Automated Insulin Delivery (AID) System (Omnipod Horizon System), to offer personalized automated insulin delivery and care for people living with diabetes. Controlled through an app
ABBOTT PARK, Ill. —Abbott and Novo Nordisk announced Wednesday a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLinkii mobile app and LibreViewiii cloud-based system). The partnership reflects both companies′ commitment to make diabetes
ABBOTT PARK, Ill. — Abbott plans to make its FreeStyle Libre flash glucose monitoring system available at major U.S. retail pharmacies before the end of the year. Approved last week by the Food and Drug Administration as a replacement for blood glucose monitoring (BGM) for adults with diabetes, the FreeStyle Libre uses new glucose sensing
